Your browser doesn't support javascript.
loading
Primary resistance to integrase strand-transfer inhibitors in Europe.
Casadellà, M; van Ham, P M; Noguera-Julian, M; van Kessel, A; Pou, C; Hofstra, L M; Santos, J R; Garcia, F; Struck, D; Alexiev, I; Bakken Kran, A M; Hoepelman, A I; Kostrikis, L G; Somogyi, S; Liitsola, K; Linka, M; Nielsen, C; Otelea, D; Paraskevis, D; Poljak, M; Puchhammer-Stöckl, E; Staneková, D; Stanojevic, M; Van Laethem, K; Zidovec Lepej, S; Clotet, B; Boucher, C A B; Paredes, R; Wensing, A M J.
Afiliação
  • Casadellà M; IrsiCaixa AIDS Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain mcasadella@irsicaixa.es.
  • van Ham PM; Department of Virology, Medical Microbiology, Utrecht Medical Centre, Utrecht, The Netherlands.
  • Noguera-Julian M; IrsiCaixa AIDS Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.
  • van Kessel A; Department of Virology, Medical Microbiology, Utrecht Medical Centre, Utrecht, The Netherlands.
  • Pou C; IrsiCaixa AIDS Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain.
  • Hofstra LM; Department of Virology, Medical Microbiology, Utrecht Medical Centre, Utrecht, The Netherlands Laboratory of Retrovirology, Luxembourg Institute of Health, Luxembourg.
  • Santos JR; HIV Unit, Hospital Universitari Germans Trias I Pujol, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain.
  • Garcia F; Complejo Hospitalario Univeristario de Granada, Instituto de Investigación IBS, Granada, Cohorte de Adultos de la Red de Investigación en SIDA (CoRIS) Spain.
  • Struck D; Laboratory of Retrovirology, Luxembourg Institute of Health, Luxembourg.
  • Alexiev I; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • Bakken Kran AM; Institute of Clinical Medicine, Oslo, Norway.
  • Hoepelman AI; Department of Virology, Medical Microbiology, Utrecht Medical Centre, Utrecht, The Netherlands.
  • Kostrikis LG; University of Cyprus, Nicosia, Cyprus.
  • Somogyi S; Robert Koch-Institute, Berlin, Germany.
  • Liitsola K; National Institute of Health and Welfare, Helsinki, Finland.
  • Linka M; National Reference Laboratory for HIV/AIDS, National Institute of Public Health, Prague, Czech Republic.
  • Nielsen C; Statens Serum Institut, Copenhagen, Denmark.
  • Otelea D; National Institute for Infectious Diseases 'Prof. Dr. Matei Bals', Bucharest, Romania.
  • Paraskevis D; National Retrovirus Reference Center, University of Athens, Athens, Greece.
  • Poljak M; Slovenian HIV/AIDS Reference Centre, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.
  • Puchhammer-Stöckl E; University of Vienna, Vienna, Austria.
  • Staneková D; Slovak Medical University, Bratislava, Slovakia.
  • Stanojevic M; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Van Laethem K; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Belgium.
  • Zidovec Lepej S; University Hospital for Infectious Diseases 'Dr. Fran Mihaljevic', Zagreb, Croatia.
  • Clotet B; IrsiCaixa AIDS Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain Universitat de Vic-Universitat Central de Catalunya, Vic, Spain Laboratory of Retrovirology, Luxembourg Institute of Health, Luxembourg.
  • Boucher CA; Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Paredes R; IrsiCaixa AIDS Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain Universitat de Vic-Universitat Central de Catalunya, Vic, Spain Laboratory of Retrovirology, Luxembourg Institute of Health, Luxembourg.
  • Wensing AM; Department of Virology, Medical Microbiology, Utrecht Medical Centre, Utrecht, The Netherlands.
J Antimicrob Chemother ; 70(10): 2885-8, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26188038
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores de Integrase de HIV / Farmacorresistência Viral Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores de Integrase de HIV / Farmacorresistência Viral Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha